A local study option for MASH
Living with fatty liver or MASH?
Novum Research is enrolling adults in two Phase 3 MASH studies in Clermont. Qualified participants receive advanced liver testing, monthly study treatment, and study-related care at no cost.
- Age 18 to 75
- Fatty liver, MASH, or signs of liver scarring
- At least two metabolic risk factors
- Able to attend regular visits in Clermont
Get a clearer picture of your liver health through advanced study testing.
Advanced testing
Understand your liver health
Every 4 weeks
Monthly study visits
No cost
Study-related care
Clermont
A local research team
More than a liver scan
A complete MASH study
This is a full MASH study—not a one-time FibroScan. Novum reviews your answers before scheduling any testing.
- 01
Advanced testing
Imaging and lab work give the team a closer look at liver fat, inflammation, and scarring.
- 02
Monthly study treatment
Researchers are studying whether a monthly medication may improve MASH and liver scarring.
- 03
A team by your side
A local research team tracks your liver health and guides you through each visit.
Who may be a good fit
More than fatty liver alone
These studies are for people with possible liver scarring and at least two metabolic risk factors. Novum will review your answers and look for the best study match.
Overweight or a larger waist
High blood pressure
Prediabetes or type 2 diabetes
High triglycerides or low HDL
Stable weight for the last 6 months
Able to attend regular visits in Clermont
Simple next steps
What happens next
- 01
Answer seven questions
Tell us about your liver health, metabolic risks, and schedule.
- 02
Talk with Novum
A coordinator reviews your answers and health history by phone.
- 03
Confirm your fit
If the study may fit, Novum schedules the tests needed to confirm.
- 04
Make your decision
Review the study details and decide whether you want to join.
Know before you decide
Questions worth asking
Quick answers about the time, testing, and next steps.
Call (352) 558-8655What are the ZENITH studies testing?
Both studies are evaluating a monthly medication called efimosfermin. Researchers want to learn whether it may improve liver scarring and resolve MASH.
What is FibroScan’s role in the study?
FibroScan is one part of screening. It estimates liver fat and stiffness but cannot confirm eligibility by itself. Other testing may include MRI, bloodwork, or a liver biopsy.
How often are visits and how long is the study?
Visits are generally every four weeks. One study lasts about a year. The other may continue for up to four years. Novum will explain the exact schedule before you decide.
Would I need a liver biopsy?
Possibly. One study requires a biopsy showing F2 or F3 MASH. The other can use a mix of non-invasive tests and, in some cases, biopsy results. Novum will explain what applies to you.
What if I have been told I have cirrhosis?
You can still complete the prescreen. Novum has separate MASH studies for some people with cirrhosis. Your answer helps the team find the right study—it does not automatically rule you out.
Does participation cost anything?
Study-related visits, testing, and treatment are provided at no cost to eligible participants. Ask Novum about possible reimbursement or compensation.
Does completing this form mean I qualify?
No. The questions help Novum decide which study to review. The research team confirms eligibility after reviewing your health history and test results.
Your next step takes about three minutes
See whether Novum should call you.
Answer seven quick questions. A coordinator will review them before deciding whether an in-person screening visit makes sense.
See if I may qualifyStudy Visits in Clermont
If the prescreen suggests a possible match, a Novum coordinator will speak with you before scheduling any in-person screening procedures.
- Novum Research290 Citrus Tower Blvd, Suite 102Clermont, FL 34711Convenient on-site parking
- HoursCall for current appointment hours
- Call Now(352) 558-8655
- AccessibilityOne-level building
Accessibility support available